June 2020
Volume 6, Issue 7
This issue explores COVID-19-associated coagulopathy, how to model professionalism in communication, and more.
Table of Contents
June 2020 Issue
Editor’s Corner: We Will Fly Again!
Travel has always been an important part of medicine, as the need to connect with colleagues in person to collaborate and learn from each...
Reader Responses: How would you treat these patients with acute stroke who are positive...
Here’s how readers responded to a You Make the Call question about anticoagulation for patients with antiphospholipid antibodies and a history of stroke.
Disclaimer: ASH...
June 2020 Issue
Predicting Survival in MM With Renal Impairment and Light Chain Cast Nephropathy
The quality of renal response to therapy was associated with survival in patients with multiple myeloma (MM) with renal impairment and light chain cast...
BTKi Improves Disease Control in CLL After Progression on Venetoclax
Treatment with a Bruton tyrosine kinase inhibitor (BTKi) showed efficacy in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) that progressed on venetoclax, according to...
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Compared with the widely used International Prognostic Index (IPI) and revised IPI (R-IPI), the most recent National Comprehensive Cancer Network IPI (NCCN-IPI) better predicts...
ASH Hosts Webinar on Treating COVID-19 With Convalescent Plasma, and more
On May 12, the American Society of Hematology (ASH) hosted a webinar on the use of convalescent plasma (i.e., plasma from patients who have...
Abnormal Coagulation Parameters Associated With Mortality in Severe Coronavirus Pneumonia
Disseminated intravascular coagulation (DIC), marked by elevated D-dimer and fibrin degradation products (FDP), is associated with a higher risk of mortality in patients with...
Ruxolitinib Improves Outcomes in Patients With Steroid-Refractory Graft-Versus-Host Disease
Patients with steroid-refractory acute graft-versus-host disease (GVHD) following hematopoietic cell transplant (HCT) experienced durable clinical responses by 28 days and had promising overall survival...
Marc J. Kahn Named Dean of UNLV School of Medicine, ASH Members Are Finalists...
Marc J. Kahn Named Dean of UNLV School of Medicine
Marc J. Kahn, MD, has been appointed the dean of the School of Medicine at...
Tisagenlecleucel Improves Patient-Reported Quality of Life in Relapsed/Refractory DLBCL
Treatment with tisagenlecleucel was associated with clinically meaningful improvements in health-related quality of life (QoL) over 18 months in patients with diffuse large B-cell...
FDA Grants CC-486 (Oral Azacitidine) Priority Review for AML Maintenance
The FDA granted priority review status to CC-486 for maintenance treatment of adult patients with acute myeloid leukemia (AML) who achieved complete remission (CR)...
UGT1A1*28 Genotype Is Associated With Reduced Overall Survival in Intermediate-Risk AML
Patients with intermediate-risk acute myeloid leukemia (AML) who are treated with cytarabine-based chemotherapy have lower overall survival (OS) if they possess the low-activity UGT1A1*28...
June 2020 Issue
Coagulation Dysregulation
Thrombosis is a major contributor to death in patients with severe coronavirus infection. As new data emerge, experts discuss approaches to prevention and treatment.
In...
Pulling Back the Curtain: Richard Aster, MD, and Jon Aster, MD, PhD
In this edition, Richard “Dick” Aster, MD, and his son, Jon Aster, MD, PhD, talk about their shared interests in research and golf.
Dick, where did...
A Hematologist Pumps Iron: Shernan Holtan, MD
In this edition of pASHions, Shernan Holtan, MD, spreads the word about powerlifting – a sport she says physicians and patients can benefit from.
Can...
FAQs From Oncologists
In this first edition of HemOnc Link, Gerald Soff, MD, sheds light on some of the most common questions that hematologists are asked by...
June 2020 Issue
How I Teach Professionalism With Ariela Marshall, MD
Ariela Marshall, MD, talks about modeling professional communication for trainees by respecting patients’ and colleagues’ differences in gender identity, culture, ethnicity, sexual orientation, and...
You Make the Call: How would you treat these patients with acute stroke who...
This month Keith R. McCrae, MD, discusses anticoagulation for patients with antiphospholipid antibodies and a history of stroke.
And don't forget to check out next month's...
